Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA)
India
· Delayed Price · Currency is INR | Market Cap | 4.27T |
| Revenue (ttm) | 503.08B |
| Net Income (ttm) | 110.54B |
| Shares Out | 2.40B |
| EPS (ttm) | 46.11 |
| PE Ratio | 38.61 |
| Forward PE | 37.55 |
| Dividend | 13.50 (0.76%) |
| Ex-Dividend Date | Jul 12, 2024 |
| Volume | 2,014,330 |
| Open | 1,772.00 |
| Previous Close | 1,777.25 |
| Day's Range | 1,758.05 - 1,791.45 |
| 52-Week Range | 1,184.50 - 1,960.35 |
| Beta | 0.55 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 31, 2024 |
About SUNPHARMA
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and othe... [Read more]
Financial Performance
In 2023, SUNPHARMA's revenue was 484.97 billion, an increase of 10.51% compared to the previous year's 438.86 billion. Earnings were 95.76 billion, an increase of 13.01%.
Financial StatementsNews
Nifty 50 top gainers today on 12 November: Trent, Infosys and Sun Pharmaceutical lead the charge
On Tuesday, Indian equity markets closed on a negative note, with the benchmark indices BSE Sensex and NSE Nifty50 both witnessing declines of over 1%. The BSE Sensex ended at 78,675.18, shedding 820....
Sun Pharmaceutical’s market cap falls ₹16,816 crore as shares decline 3.92%
Sun Pharmaceutical Industries Limited experienced a sharp decline in its market capitalization, dropping by approximately ₹16,816 crore as its shares fell 3.92% to ₹1,785.50 on the NSE. This downturn ...
Sun Pharmaceutical shares decline nearly 5% as US court blocks LEQSELVI launch
Sun Pharmaceutical Industries faced a decline in shares after the US District Court of New Jersey issued a preliminary injunction preventing the company from launching its drug ‘LEQSELVI’ for severe a...
Nomura maintains neutral on Sun Pharma with slight downside, sets target price at Rs 1,850
Nomura has maintained a “Neutral” rating on Sun Pharmaceutical, setting a target price of ₹1,850, suggesting a slight downside from the current market price (CMP) of ₹1,860. This follows the recent de...
Stocks to watch today on November 4: InfoEdge, NCC, Apollo Hospitals, Sun Pharma and more
Here’s a roundup of stocks that are expected to be in focus on November 4: Stocks with potential positive move: InfoEdge: Naukri JobSpeak Index saw a 10% year-on-year increase in October, indicating a...
Sun Pharma profit up 28% on higher sales
India Business News: Sun Pharma reported a 28% increase in consolidated net profit for the second quarter ended September, at Rs 3,040 crore, with sales up by 9% to Rs 13,.
Sun Pharma shares rise nearly 3% post Q2 results; revenue grows 9% YoY to ₹13,291 crore, net profit jumps 27.5%
Sun Pharmaceutical Industries shares surge nearly 3% post Q2 results – Sun Pharma Q2 FY25 Results: Revenue grows 9% YoY to ₹13,291 crore, Net Profit jumps 27.5% YoY to ₹3,040 crore Sun Pharmaceutical ...
Sun Pharma Q2 FY25 Results Revenue grows 9%% YoY to ₹13,291.39 crore, Net Profit jumps 27.5% YoY to ₹3,040.1 crore
Sun Pharmaceutical Industries Limited reported robust Q2 FY25 financial results, reflecting strong year-over-year (YoY) growth in both revenue and net profit. The company continues to outperform marke...
Punjab National Bank shares surge nearly 4% ahead of Q2 results
Punjab National Bank (PNB) saw its share price rise by nearly 4% in the lead-up to its Q2 FY25 earnings announcement. As of 10:30 am, PNB shares were trading 3.29% higher at ₹98.87, reflecting investo...
Stock market update: Q2 FY25 results today for Bharti Airtel, IOC, Sun Pharma, Ambuja Cements, Adani Power, PNB, Suzlon, BHEL and more
Several major companies across sectors are set to announce their Q2 FY25 results today. Here’s a brief look at what to watch for: Bharti Airtel: Focus on ARPU growth and 5G expansion. IOC: Key metrics...
Studies Show Sun Pharma's WINLEVI® (clascoterone) Cream 1% Reduces Sebum Levels and is Suitable for Combination With Other Commonly Used Topical Acne Medications
WINLEVI poster presentations at 2024 Fall Clinical Dermatology Conference also include data affirming reduced acne severity and tolerability in patients with skin of color. MUMBAI , India and PRINCETO...
Stock Market update: Mahindra & Mahindra, Sun Pharmaceutical among Nifty 50 top losers today
The Indian benchmark equity indices, the BSE Sensex and the NSE Nifty50, both closed in the red on Wednesday. The BSE Sensex dropped 138.74 points (0.17 percent) to 80,081.98. On the other hand, the N...
Nifty Pharma hits record high, Divi’s Lab surges 5.83%, Cipla up 1.75%
he Nifty Pharma Index soared to record levels today, driven by strong performances across major pharmaceutical stocks. At 11:12 AM, Divi’s Laboratories led the rally, surging by 5.83%, followed by not...
UBS maintains Buy call on Sun Pharma, expects 28% upside in share price
UBS has maintained its ‘Buy’ rating on Sun Pharma, setting a target price of ₹2450, indicating a strong upside potential. UBS expects specialty products to contribute over 30% of the company’s profits...
Sun Pharma and Philogen enter into global licensing agreement for commercializing Fibromun
Sun Pharmaceutical Industries Limited and Philogen announced today that they have signed a global licensing agreement to commercialize Philogen’s speciality product, Fibromun. Fibromun, an innovative ...
No stocks under F&O ban today; Bandhan Bank and RBL Bank close to limits
Indian benchmark indices ended lower on September 27, with the Nifty slipping below 26,200. The BSE Midcap and Smallcap indices remained relatively flat. The top losers on the Nifty included Power Gri...
Stocks to Watch: RIL, Adani Enterprises, BEL, GAIL, Kaynes Technology, Lupin, Jubilant Pharma, Zomato and morein focus today (Sept 30, 2024)
Indian benchmark indices ended lower on September 27, with the Nifty slipping below 26,200. The BSE Midcap and Smallcap indices remained relatively flat. The top losers on the Nifty included Power Gri...
ICICI Prudential Focused Equity Fund delivers 56.66% return in last year, 94.78% over 3 years, with top holdings in ICICI Bank & Sun Pharmaceutical Industries
ICICI Prudential Focused Equity Fund Direct-Growth is an equity mutual fund offered by ICICI Prudential Mutual Fund. The fund has an AUM of ₹10,093.43 Crores and the current NAV is ₹105.590 as of Sept...
Sensex hits record high at 85,955 as Nifty gains, large caps outpace mid and small caps
On Friday, Indian equity benchmark indices BSE Sensex and Nifty50 maintained their upward momentum. Infosys, TCS, and Sun Pharma emerged as top gainers. Meanwhile, financial indices such as Nifty Bank...
Sun Pharma and Moebius Medical get USFDA nod for MM-II for treatment of osteoarthritis knee pain
Sun Pharma and Israel-based Moebius Medical Limited announced that MM-II (Large Liposomes of DPPC and DMPC) has received Fast Track designation (FTD) from the United States Food and Drug Administratio...
Stock Market News: Sona BLW, RIL, PNB Housing Finance, Suzlon among top stocks to watch today (Sept 5, 2024)
Nifty closed below 25,200 as the Sensex dropped 203 points. Top gainers on the Nifty include Asian Paints, Grasim Industries, HUL, Apollo Hospitals, and Sun Pharma. Wipro, Coal India, ONGC, Hindalco I...
Sun Pharmaceutical introduces STARIZO in India for acute bacterial skin and skin structure infections
Sun Pharmaceutical Industries Limited recently announced the introduction of Tedizolid Phosphate tablets 200 mg in India under the brand name “STARIZO”. STARIZO (Tedizolid Phosphate) is a new oxazolid...
Punjab eyes investments as CM Mann meets industry leaders in Mumbai
Punjab Chief Minister Bhagwant Mann successfully attracts investments from leading companies like Sun Pharmaceutical Industries Ltd, RPG, Sify Technologies, and JSW Group during his visit to Mumbai.